ProJenX partners with Unlearn to use AI-generated digital twins in ALS trial

By Yahoo! Finance | Sep 27, 2024 at 04:12 AM EST

ProJenX collaborates with Unlearn to utilize generative AI technology in a Phase I trial for prosetin, a potential ALS treatment. Digital twins created by Unlearn will aid in evaluating clinical outcomes and enhancing the trial process efficiently.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.